93 related articles for article (PubMed ID: 21840429)
1. Fucosylated glycoproteomic approach to identify a complement component 9 associated with squamous cell lung cancer (SQLC).
Narayanasamy A; Ahn JM; Sung HJ; Kong DH; Ha KS; Lee SY; Cho JY
J Proteomics; 2011 Nov; 74(12):2948-58. PubMed ID: 21840429
[TBL] [Abstract][Full Text] [Related]
2. Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.
Ahn JM; Sung HJ; Yoon YH; Kim BG; Yang WS; Lee C; Park HM; Kim BJ; Kim BG; Lee SY; An HJ; Cho JY
Mol Cell Proteomics; 2014 Jan; 13(1):30-48. PubMed ID: 24085812
[TBL] [Abstract][Full Text] [Related]
3. Fucosylation of serum glycoproteins in lung cancer patients.
Kossowska B; Ferens-Sieczkowska M; Gancarz R; Passowicz-Muszyńska E; Jankowska R
Clin Chem Lab Med; 2005; 43(4):361-9. PubMed ID: 15899650
[TBL] [Abstract][Full Text] [Related]
4. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.
Wu J; Xie X; Liu Y; He J; Benitez R; Buckanovich RJ; Lubman DM
J Proteome Res; 2012 Sep; 11(9):4541-52. PubMed ID: 22827608
[TBL] [Abstract][Full Text] [Related]
5. Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer.
Balmaña M; Giménez E; Puerta A; Llop E; Figueras J; Fort E; Sanz-Nebot V; de Bolós C; Rizzi A; Barrabés S; de Frutos M; Peracaula R
J Proteomics; 2016 Jan; 132():144-54. PubMed ID: 26563517
[TBL] [Abstract][Full Text] [Related]
6. Development of an AlphaLISA assay to quantify serum core-fucosylated E-cadherin as a metastatic lung adenocarcinoma biomarker.
Wen CL; Chen KY; Chen CT; Chuang JG; Yang PC; Chow LP
J Proteomics; 2012 Jul; 75(13):3963-76. PubMed ID: 22634079
[TBL] [Abstract][Full Text] [Related]
7. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
8. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer.
Tsai HY; Boonyapranai K; Sriyam S; Yu CJ; Wu SW; Khoo KH; Phutrakul S; Chen ST
Proteomics; 2011 Jun; 11(11):2162-70. PubMed ID: 21538882
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of plasma C9 protein in gastric cancer patients.
Chong PK; Lee H; Loh MC; Choong LY; Lin Q; So JB; Lim KH; Soo RA; Yong WP; Chan SP; Smoot DT; Ashktorab H; Yeoh KG; Lim YP
Proteomics; 2010 Sep; 10(18):3210-21. PubMed ID: 20707004
[TBL] [Abstract][Full Text] [Related]
10. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of abnormally-fucosylated haptoglobins in cancer sera.
Thompson S; Turner GA
Br J Cancer; 1987 Nov; 56(5):605-10. PubMed ID: 3426924
[TBL] [Abstract][Full Text] [Related]
12. α1-3/4 fucosylation at Asn 241 of β-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers.
Park SY; Lee SH; Kawasaki N; Itoh S; Kang K; Hee Ryu S; Hashii N; Kim JM; Kim JY; Hoe Kim J
Int J Cancer; 2012 May; 130(10):2366-76. PubMed ID: 21780104
[TBL] [Abstract][Full Text] [Related]
13. Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer.
Liang Y; Ma T; Thakur A; Yu H; Gao L; Shi P; Li X; Ren H; Jia L; Zhang S; Li Z; Chen M
Glycobiology; 2015 Mar; 25(3):331-40. PubMed ID: 25347993
[TBL] [Abstract][Full Text] [Related]
14. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
[TBL] [Abstract][Full Text] [Related]
15. Glycoproteomic identification of novel plasma biomarkers for oral cancer.
Chang SC; Lin WL; Chang YF; Lee CT; Wu JS; Hsu PH; Chang CF
J Food Drug Anal; 2019 Apr; 27(2):483-493. PubMed ID: 30987719
[TBL] [Abstract][Full Text] [Related]
16. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.
Comunale MA; Lowman M; Long RE; Krakover J; Philip R; Seeholzer S; Evans AA; Hann HW; Block TM; Mehta AS
J Proteome Res; 2006 Feb; 5(2):308-15. PubMed ID: 16457596
[TBL] [Abstract][Full Text] [Related]
18. Pathways enrichment analysis for differentially expressed genes in squamous lung cancer.
Qian L; Luo Q; Zhao X; Huang J
Pathol Oncol Res; 2014 Jan; 20(1):197-202. PubMed ID: 24114512
[TBL] [Abstract][Full Text] [Related]
19. Fucosylated forms of alpha-1-antitrypsin that predict unresponsiveness to chemotherapy in ovarian cancer.
Thompson S; Guthrie D; Turner GA
Br J Cancer; 1988 Nov; 58(5):589-93. PubMed ID: 3265332
[TBL] [Abstract][Full Text] [Related]
20. Development of a combined chemical and enzymatic approach for the mass spectrometric identification and quantification of aberrant N-glycosylation.
Chen R; Wang F; Tan Y; Sun Z; Song C; Ye M; Wang H; Zou H
J Proteomics; 2012 Feb; 75(5):1666-74. PubMed ID: 22202184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
